hepatitis

Medcis Pathlabs and its associates and attendees will buy Co-Diagnostics' tests for hepatitis B, hepatitis C, HIV, and human papillomavirus.

Hologic CEO Steve MacMillan said that the deal is so compelling that the firm needed to do it now.

The test enables donor screening laboratories to use PCR-based diagnostic technology to screen donated blood and plasma.

Professional, molecular, and tissue diagnostics sales continued to grow during the first three quarters, while diabetes care sales remained in decline.

Roche's molecular diagnostics business, which makes up 17 percent of its overall diagnostics sales, grew 11 percent, driven by virology testing and sequencing.

The virus, known as HPgV-2, was detected in blood samples from individuals with concurrent hepatitis C virus infections.

It's the first approved test to feature the firm's proprietary AmpiProbe nucleic acid amplification and detection platform.

A survey of small mammals from around the world uncovered new and known hepatoviruses that are helping to clarify relationships between viral clades.